journal
MENU ▼
Read by QxMD icon Read
search

Growth Hormone & IGF Research

journal
https://www.readbyqxmd.com/read/28157571/cortistatin-a-new-link-between-the-growth-hormone-prolactin-axis-stress-and-metabolism
#1
REVIEW
Alejandro Ibáñez-Costa, Raúl M Luque, Justo P Castaño
Cortistatin is a neuropeptide originally identified in cortical brain regions, which displays a high structural and functional homology with somatostatin. However, cortistatin possesses distinct, unique functions, in the immune and central nervous systems, and it also shows specific endocrine effects, particularly on pituitary growth hormone, prolactin and adrenocorticotropin axes. Somatostatin and cortistatin bind similarly to the five native somatostatin receptors, sst1-sst5, whereas both compounds bind differentially to the recently discovered truncated variants of the sst subtype 5 (sst5TMD4, sst5TMD5); moreover, only cortistatin is able to bind other non-sst receptors (GHS-R and MrgX2)...
January 22, 2017: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/28129571/investigation-of-igf2-igfbp2-and-p63-proteins-in-rhabdomyosarcoma-tumors
#2
Yongbo Yu, Libing Fu, Shen Wang, Yaqiong Jin, Shujing Han, Ping Chu, Jie Lu, Yongli Guo, Lejian He, Xin Ni
: Many efforts have been made to address involvement of the insulin-like growth-factor (IGF) pathway in rhabdomyosarcoma (RMS) pathogenesis, but the actual role of IGF in RMS is still controversial. OBJECTIVE: To investigate the implications of IGF2, IGFBP2 and p63 in RMS, and further explored their potential interaction. DESIGN: A total of 114 specimens of RMS along with clinic-pathologic characteristics were collected from the year of 2003 to 2013...
January 13, 2017: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/28110155/first-in-man-study-with-a-novel-pegylated-recombinant-human-insulin-like-growth-factor-i
#3
H Kletzl, A Guenther, A Höflich, C Höflich, J Frystyk, R F Staack, E Schick, C Wandel, N Bleich, F Metzger
OBJECTIVE: This study is a first time assessment of safety and tolerability, pharmacokinetics, and pharmacodynamics of RO5046013 in human, in comparison with unmodified rhIGF-I. DESIGN: The study was conducted as a single-center, randomized, double-blinded, placebo-controlled, single ascending dose, parallel group study in a clinical research unit in France. A total of 62 healthy volunteers participated in this clinical trial. RO5046013 was given as single subcutaneous injection, or as intravenous infusion over 48h, at ascending dose levels...
January 10, 2017: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/28011098/serum-igf-i-igfbp-3-and-als-concentrations-and-physical-performance-in-young-swimmers-during-a-training-season
#4
H Tourinho Filho, M Pires, E F Puggina, M Papoti, R Barbieri, C E Martinelli
INTRODUCTION: The GH/IGF-I axis is a system of growth mediators, receptors, and binding proteins that regulate somatic and tissue growth; and it has been shown that exercise programs are related to the anabolic function of this axis. OBJECTIVE: The aim of this study was to analyse the changes of serum IGF-I concentration and that of its binding proteins IGFBP-3 and ALS in adolescent swimmers at different stages of a training season, and compare them with physical performance parameters and body composition of the athletes...
December 18, 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/28017505/endurance-training-induced-changes-in-the-gh-igf-i-axis-influence-maximal-muscle-strength-in-previously-untrained-men
#5
Marcin Grandys, Joanna Majerczak, Piotr Kuczek, Krystyna Sztefko, Krzysztof Duda, Jerzy A Zoladz
OBJECTIVE: In this study we have determined the effects of 20weeks of endurance running training on the GH-IGF-I axis changes in the context of the skeletal muscle performance and physical capacity level. DESIGN: Before and after the endurance training program a maximal incremental exercise tests, a 1500m race and a muscle strength measurements were performed and the blood samples were taken to determine both resting as well as end-exercise serum growth hormone (GH), insulin-like growth hormone-I (IGF-I), insulin-like growth hormone binding protein-3 (IGFBP-3) and plasma interleukin-6 (IL-6) concentrations...
December 15, 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/28007336/the-combined-frequency-of-igf-and-myostatin-polymorphism-among-track-field-athletes-and-swimmers
#6
Sigal Ben-Zaken, Yoav Meckel, Dan Nemet, Alon Eliakim
OBJECTIVE: The IGF C-1245T (rs35767) and the myostatin (MSTN) Lys(K)-153Arg(R) genetic polymorphism may influence skeletal muscle phenotypes and athletic performance. Carrying the minor IGF T allele and the myostatin rare R allele was associated with higher circulating IGF-I levels, greater muscle mass and improved performance. The aim of the present study was to assess the combined frequency of the IGF 1245T (rs35767) and MSTN 153Arg(R) polymorphism among Israeli track and field athletes (n=111) and swimmers (n=80)...
December 15, 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/27979730/differential-basal-and-exercise-induced-igf-i-system-responses-to-resistance-vs-calisthenic-based-military-readiness-training-programs
#7
Bradley C Nindl, Joseph A Alemany, Kevin R Rarick, Shawn R Eagle, Mathew E Darnell, Katelyn F Allison, Everett A Harman
OBJECTIVE: The purpose of this study was to: 1) evaluate differential responses of the IGF-I system to either a calisthenic- or resistance exercise-based program and 2) determine if this chronic training altered the IGF-I system during an acute resistance exercise protocol. DESIGN: Thirty-two volunteers were randomly assigned into a resistance exercise-based training (RT) group (n=15, 27±5y, 174±6cm, 81±12kg) or a calisthenic-based training group (CT) (n=17, 29±5y, 179±8cm, 85±10kg) and all underwent 8weeks of exercise training (1...
December 6, 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/28214503/editorial
#8
EDITORIAL
(no author information available yet)
No abstract text is available yet for this article.
February 2017: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/27919008/phenotype-analysis-of-male-transgenic-mice-overexpressing-mutant-igfbp-2-lacking-the-cardin-weintraub-sequence-motif-reduced-expression-of-synaptic-markers-and-myelin-basic-protein-in-the-brain-and-a-lower-degree-of-anxiety-like-behaviour
#9
N Schindler, J Mayer, S Saenger, U Gimsa, C Walz, J Brenmoehl, D Ohde, E Wirthgen, A Tuchscherer, V C Russo, M Frank, T Kirschstein, F Metzger, A Hoeflich
Brain growth and function are regulated by insulin-like growth factors I and II (IGF-I and IGF-II) but also by IGF-binding proteins (IGFBPs), including IGFBP-2. In addition to modulating IGF activities, IGFBP-2 interacts with a number of components of the extracellular matrix and cell membrane via a Cardin-Weintraub sequence or heparin binding domain (HBD1). The nature and the signalling elicited by these interactions are not fully understood. Here, we examined transgenic mice (H1d-hBP2) overexpressing a mutant human IGFBP-2 that lacks a specific heparin binding domain (HBD1) known as the Cardin-Weintraub sequence...
November 16, 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/27836414/identification-of-the-igf-1-processing-product-human-ec-rodent-eb-peptide-in-various-tissues-evidence-for-its-differential-regulation-after-exercise-induced-muscle-damage-in-humans
#10
George Vassilakos, Anastassios Philippou, Michael Koutsilieris
OBJECTIVE: Insulin-like growth factor-1 (IGF-1) is a pleiotropic factor expressed in various tissues and plays a critical role in skeletal muscle physiology. Alternative splicing of the IGF-1 gene gives rise to different precursor polypeptides (isoforms) which could undergo post-translational cleavage, generating the common mature IGF-1 peptide and different carboxyl terminal extension (E-) peptides, with the fate of the latter being, so far, unknown. The objective if this study was to identify the IGF-1Ec forms or processing product(s), other than mature IGF-1, generated in different human and rodent tissues and particularly in human skeletal muscle after exercise-induced damage...
November 4, 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/27789212/multi-modal-exercise-training-and-protein-pacing-enhances-physical-performance-adaptations-independent-of-growth-hormone-and-bdnf-but-may-be-dependent-on-igf-1-in-exercise-trained-men
#11
Stephen J Ives, Chelsea Norton, Vincent Miller, Olivia Minicucci, Jake Robinson, Gabe O'Brien, Daniela Escudero, Maia Paul, Caitlin Sheridan, Kathryn Curran, Kayla Rose, Nathaniel Robinson, Feng He, Paul J Arciero
OBJECTIVE: Protein-pacing (P; 5-6meals/day @ 2.0g/kgBW/day) and multi-mode exercise (RISE; resistance, interval, stretching, endurance) training (PRISE) improves muscular endurance, strength, power and arterial health in exercise-trained women. The current study extends these findings by examining PRISE on fitness, growth hormone (GH), insulin-like growth factor-1 (IGF-1), and brain-derived neurotrophic factor (BDNF) response, cardiometabolic health, and body composition in exercise-trained men...
October 15, 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/27726925/the-effect-of-hmb-ingestion-on-the-igf-i-and-igf-binding-protein-response-to-high-intensity-military-training
#12
Michael J Redd, Jay R Hoffman, Yftach Gepner, Jeffrey R Stout, Mattan W Hoffman, Daniel Ben-Dov, Shany Funk, David D Church, Guy Avital, Yacov Chen, Hagai Frankel, Ishay Ostfeld
OBJECTIVE: Insulin-like growth factor-I (IGF-I) is a metabolic and anabolic biomarker that has been proposed to reflect physiological adaptations resulting from multistressor environments. The bioactivity of IGF-I is regulated by seven different insulin-like growth factor binding proteins (IGFBPs) which act not only as carriers of IGF-1, but also function as a modulator of IGF-I availability and activity. Supplementing with β-hydroxy-β-methylbutyrate (HMB) has been shown to enhance physiological outcomes associated with intense training, and has been reported to augment the IGF-1 response...
October 5, 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/27863277/vitamin-d-supplementation-affects-the-igf-system-in-men-after-acute-exercise
#13
Rachel L Darr, Kathleen J Savage, Mark Baker, Gregory E Wilding, Amy Raswalsky, Todd Rideout, Richard W Browne, Peter J Horvath
OBJECTIVE: Contradictory data between the Insulin-Like Growth Factor System (IGF) system and exercise may be due to alteration in IGF binding proteins. Vitamin D (D) deficiency has been related to muscle weakness and Insulin Like Growth Factor Binding Protein 3 (IGFBP3). A Vit. D and acute exercise merge is proposed to modify the IGF system. DESIGN: D insufficient and deficient men (39.0±8.6yo with serum D (25OH D) 20.0±7.7ng/mL) did 1h of stretching (ST), aerobic (AB), and resistance (RT) exercises, before and after 28d of 4000IU/d Vit...
October 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/27792888/discrepancies-in-insulin-like-growth-factor-signaling-no-not-really
#14
Cheryl A Conover
Why do studies on insulin-like growth factors (IGFs) and IGF signaling seem so contradictory? The answer is "It depends". This mini- review will explore a few of the factors that are likely to contribute to a seemingly confusing message. Most of the evidence comes from experimental animal models.
October 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/27756606/screening-for-genetic-causes-of-growth-hormone-hypersecretion
#15
REVIEW
Liliya Rostomyan, Albert Beckers
Growth hormone (GH) secreting pituitary tumors may be caused by genetic abnormalities in a variety of genes including AIP, MEN1, CDKN1B, and PRKAR1A. These can lead to GH secreting pituitary adenomas as an isolated occurrence (e.g. as aggressive sporadic adenomas or in familial isolated pituitary adenomas (FIPA)) or as part of syndromic conditions such as MEN1 or Carney complex. These tumors have more aggressive features than sporadic acromegaly, including a younger age at disease onset and larger tumor size, and they can be challenging to manage...
October 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/27745780/new-medical-therapies-of-acromegaly
#16
REVIEW
F Maffezzoni, S Frara, M Doga, G Mazziotti, A Giustina
Acromegaly is a rare disease associated with significant morbidity and increased mortality. Treatment of acromegaly aims at controlling growth hormone hypersecretion, improving patients' symptoms and comorbidities and normalizing mortality. The therapeutic options for acromegaly include surgery, medical therapies and radiotherapy. However, despite all these treatment options, approximately one-half of patients are not adequately controlled. Progress in molecular research has made possible to develop new therapeutic strategies to improve control of acromegaly...
October 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/27743704/gigantism-x-linked-acrogigantism-and-gpr101-mutations
#17
REVIEW
Donato Iacovazzo, Márta Korbonits
X-linked acrogigantism (XLAG) is a recently identified condition of early-onset GH excess resulting from the germline or somatic duplication of the GPR101 gene on chromosome Xq26.3. Thirty patients have been formally reported so far. The disease affects mostly females, occurs usually sporadically, and is characterised by early onset and marked overgrowth. Most patients present with concomitant hyperprolactinaemia. Histopathology shows pituitary hyperplasia or pituitary adenoma with or without associated hyperplasia...
October 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/27720550/igf-i-in-the-clinics-use-in-retinopathy-of-prematurity
#18
REVIEW
Ann Hellström, David Ley, Ingrid Hansen-Pupp, Boubou Hallberg, Luca A Ramenghi, Chatarina Löfqvist, Lois E H Smith, Anna-Lena Hård
Retinopathy of prematurity is a potentially blinding disease, which is associated with low neonatal IGF-I serum concentrations and poor growth. In severe cases impaired retinal vessel growth is followed by pathologic neovascularization, which may lead to retinal detachment. IGF-I may promote growth even in catabolic states. Treating preterm infants with recombinant human (rh) IGF-I to concentrations normally found during gestation has been suggested to have a preventative effect on ROP. A recent phase 2 study treating infants (gestational age between 23weeks+0days and 27weeks +6days) with rhIGF-I/IGF binding protein-3 until 30 postmenstrual weeks showed no effect on ROP but a 53% reduction in severe bronchopulmonary dysplasia and 44% reduction in severe intraventricular hemorrhage...
October 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/27712893/two-years-in-igf-research
#19
REVIEW
Briony E Forbes
The last two years of insulin-like growth factor (IGF) research has yielded a vast literature highlighting the central role IGFs factors play in processes such as development, growth, aging and neurological function. It also provides our latest understanding of how IGF system perturbation is linked to diseases including growth deficiency, cancer, and neurological and cardiovascular diseases. A snapshot of the highlights is presented in this review, focussing on the topics of IGFs and growth, comparative and structural biology to understand insulin-like peptide function, IGFs and cancer, and IGFs and neurological function...
October 2016: Growth Hormone & IGF Research
https://www.readbyqxmd.com/read/27681092/current-ideas-on-the-biology-of-igfbp-6-more-than-an-igf-ii-inhibitor
#20
REVIEW
Leon A Bach
IGFBP-6 binds IGF-II with higher affinity than IGF-I and it is a relatively specific inhibitor of IGF-II actions. More recently, IGFBP-6 has also been reported to have IGF-independent effects on cell proliferation, survival, differentiation and migration. IGFBP-6 binds to several ligands in the extracellular space, cytoplasm and nucleus. These interactions, together with activation of distinct intracellular signaling pathways, may contribute to its IGF-independent actions; for example, IGF-independent migration induced by IGFBP-6 involves interaction with prohibitin-2 and activation of MAP kinase pathways...
October 2016: Growth Hormone & IGF Research
journal
journal
33075
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"